Expression and distribution of aggrecanases in human larynx: ADAMTS-5/aggrecanase-2 is the main aggrecanase in laryngeal carcinoma

Biochimie

Volumn 95, Issue 4, 2013, Pages 725-734

  Filou, S ^a   Stylianou, M ^a   Triantaphyllidou, I E ^a   Papadas, T ^b   Mastronikolis, N S ^b   Goumas, P D ^b   Papachristou, D J ^a   Ravazoula, P ^b   Skandalis, S S ^a   Vynios, D H ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

ADAMTS 5; Aggrecan; Aggrecanases; Cartilage; Extractability; Laryngeal cancer

Indexed keywords

ADAMTS1 PROTEIN; AGGRECANASE 1; AGGRECANASE 2; MESSENGER RNA;

ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX; LARYNX CARCINOMA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADAM PROTEINS; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARYNGEAL NEOPLASMS; LARYNX; MALE; PROCOLLAGEN N-ENDOPEPTIDASE; PROTEIN TRANSPORT; RNA, MESSENGER;

EID: 84874666262     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.10.022     Document Type: Article

References (48)

1. N.S. Mastronikolis, T.A. Papadas, P.D. Goumas, I.E. Triantaphyllidou, D.A. Theocharis, N. Papageorgakopoulou, and D.H. Vynios In solid tumour section: 'head and neck: laryngeal tumors: an overview' Atlas Genet. Cytogenet. Oncol. Haematol. 13 11 2009 888 893
2. C.B. Knudson, and W. Knudson Cartilage proteoglycans Semin. Cell. Dev. Biol. 12 2001 69 78
3. S.S. Skandalis, A.D. Theocharis, D.H. Vynios, D.A. Theocharis, and N. Papageorgakopoulou Proteoglycans in human laryngeal cartilage. Identification of proteoglycan types in successive cartilage extracts with particular reference to aggregating proteoglycans Biochimie 86 2004 221 229
4. T.E. Hardingham, A.J. Fosang, and J. Dudhia The structure, function and turnover of aggrecan, the large aggregating proteoglycan from cartilage Eur. J. Clin. Chem. Clin. Biochem. 32 1994 249 257
5. T.E. Hardingham, and A.J. Fosang Proteoglycans: many forms and many functions FASEB J. 6 1992 861 870
6. S.S. Skandalis, A.D. Theocharis, D.A. Theocharis, Th. Papadas, D.H. Vynios, and N. Papageorgakopoulou Matrix proteoglycans are markedly affected in advanced laryngeal squamous cell carcinoma Biochim. Biophys. Acta 1689 2004 152 161
7. S.S. Skandalis, D.A. Theocharis, N. Papageorgakopoulou, and D.H. Vynios The extractability of extracellular matrix components as a marker of cartilage remodeling in laryngeal squamous cell carcinoma Biochim. Biophys. Acta 1721 2005 81 88
8. S.S. Skandalis, A.D. Theocharis, D.H. Vynios, N. Papageorgakopoulou, A. Hjerpe, N.K. Karamanos, and D.A. Theocharis Cartilage aggrecan undergoes significant compositional and structural alterations during laryngeal cancer Biochim. Biophys. Acta 1760 2006 1046 1053
9. T.A. Christopoulos, N. Papageorgakopoulou, D.A. Theocharis, A.J. Aletras, C.P. Tsiganos, T.A. Papadas, N.S. Mastronikolis, P. Goumas, and D.H. Vynios Diagnostic and classification value of metalloproteinases in squamous human laryngeal carcinoma Int. J. Oncol. 25 2004 481 485
10. T.A. Christopoulos, N. Papageorgakopoulou, D.A. Theocharis, N.S. Mastronikolis, Th. Papadas, and D.H. Vynios Hyaluronidase and CD44 hyaluronan receptor expression in squamous cell laryngeal carcinoma Biochim. Biophys. Acta 1760 2006 1039 1045
11. T.A. Christopoulos, N. Papageorgakopoulou, P. Ravazoula, N.S. Mastronikolis, Th. Papadas, D.A. Theocharis, and D.H. Vynios Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma Oncol. Rep. 18 2007 855 860
12. H. Nagase, and M. Kashiwagi Aggrecanases and cartilage matrix degradation Arthritis Res. Ther. 5 2003 94 103
13. R.Q. Liu, and J.M. Trzaskos Aggrecanase: the family and its inhibitors Curr. Med. Chem. 4 2005 251 264
14. S.S. Apte A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family Int. J. Biochem. Cell. Biol. 36 2004 981 985
15. C.R. Flannery MMPs and ADAMTSs: functional studies Front. Biosci. 11 2006 544 569
16. J.D. Sandy A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis Osteoarthr. Cartil. 14 2006 95 100
17. M.D. Tortorella, T.C. Burn, M.A. Pratta, I. Abbaszade, J.M. Hollis, R. Liu, S.A. Rosenfeld, R.A. Copeland, C.P. Decicco, R. Wynn, A. Rockwell, F. Yang, J.L. Duke, K. Solomon, H. George, R. Bruckner, H. Nagase, Y. Itoh, D.M. Ellis, H. Ross, B.H. Wiswall, K. Murphy, M.C. Hillman Jr., G.F. Hollis, R.C. Newton, R.L. Magolda, J.M. Trzaskos, and E.C. Arner Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins Science 284 1999 664 666
18. I. Abbaszade, R.Q. Liu, F. Yang, S.A. Rosenfeld, O.H. Ross, J.R. Link, D.M. Ellis, M.D. Tortorella, M.A. Pratta, J.M. Hollis, R. Wynn, J.L. Duke, H.J. George, M.C. Hillman Jr., K. Murphy, B.H. Wiswall, R.A. Copeland, C.P. Decicco, R. Bruckner, H. Nagase, Y. Itoh, R.C. Newton, R.L. Magolda, J.M. Trzaskos, and T.C. Burn Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family J. Biol. Chem. 274 1999 23443 23450
19. K. Kuno, Y. Okada, H. Kawashima, H. Nakamura, M. Miyasaka, H. Ohno, and K. Matsushima ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan FEBS Lett. 478 2000 241 245
20. L.A. Collins-Racie, C.R. Flannery, W. Zeng, C. Corcoran, B. Annis-Freeman, M.J. Agostino, M. Arai, E. DiBlasio Smith, A.J. Dorner, K.E. Georgiadis, M. Jin, X.Y. Tan, E.A. Morris, and E.R. LaVallie ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage Matrix. Biol. 23 2004 219 230
21. R.P. Somerville, J.M. Longpre, K.A. Jungers, J.M. Engle, M. Ross, S. Evanko, T.N. Wight, R. Leduc, and S.S. Apte Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1 J. Biol. Chem. 278 2003 9503 9513
22. W. Zeng, C. Corcoran, L.A. Collins-Racie, E.R. LaVallie, E.A. Morris, and C.R. Flannery Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18 Biochim. Biophys. Acta 1760 2006 517 524
23. C.J. Billington, I.M. Clark, and T.E. Cawston An aggrecan-degrading activity associated with chondrocyte membranes Biochem. J. 336 1998 207 212
24. F.M. Rogerson, H. Stanton, C.J. East, S.B. Golub, L. Tutolo, P.J. Farmer, and A.J. Fosang Evidence of a novel aggrecan-degrading activity in cartilage: studies of mice deficient in both ADAMTS-4 and ADAMTS-5 Arthritis Rheum. 58 2008 1664 1673
25. K. Huang, and L.D. Wu Aggrecanase and aggrecan degradation in osteoarthritis: a review J. Int. Med. Res. 36 2008 1149 1160
26. A. Colige, A. Beschin, B. Samyn, Y. Goebels, J. van Beeumen, B.V. Nusgens, and C.M. Lapière Characterization and partial amino acid sequencing of a 107-kDa procollagen I N-proteinase purified by affinity chromatography on immobilized type XIV collagen J. Biol. Chem. 270 1995 16724 16730
27. R.J. Fernandes, S. Hirohata, J.M. Engle, A. Colige, D.H. Cohn, D.R. Eyre, and S.S. Apte Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis J. Biol. Chem. 276 2001 31502 31509
28. A. Colige, I. Vandenberghe, M. Thiry, C.A. Lambert, J. van Beeumen, S.W. Li, D.J. Prockop, C.M. Lapière, and B.V. Nusgens Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3 J. Biol. Chem. 277 2002 5756 5766
29. M. Furlan, R. Robles, M. Galbusera, G. Remuzzi, P.A. Kyrle, B. Brenner, M. Krause, I. Scharrer, V. Aumann, U. Mittler, M. Solenthaler, and B. Lammle Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N. Engl. J. Med. 339 1998 1578 1584
30. F. Vazquez, G. Hastings, M.A. Ortega, T.F. Lane, S. Oikemus, M. Lombardo, and M.L. Iruela-Arispe METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity J. Biol. Chem. 274 1999 23349 23357
31. J.S. Richards, I. Hernandez-Gonzalez, I. Gonzalez-Robayna, E. Teuling, Y. Lo, D. Boerboom, A.E. Falender, K.H. Doyle, R.G. LeBaron, V. Thompson, and J.D. Sandy Regulated expression of ADAMTS family members in follicles and cumulus oocyte complexes: evidence for specific and redundant patterns during ovulation Biol. Reprod. 72 2005 1241 1255
32. S.S. Skandalis, A.D. Theocharis, N. Papageorgakopoulou, D.H. Vynios, and D.A. Theocharis The increased accumulation of structurally modified versican and decorin is related with the progression of laryngeal cancer Biochimie 88 2006 1135 1143
33. P. Wang, M. Tortorella, K. England, A.M. Malfait, G. Thomas, E.C. Arner, and D. Pei Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network J. Biol. Chem. 279 2004 15434 15440
34. G. Gao, A. Plaas, V.P. Thompson, S. Jin, F. Zuo, and J.D. Sandy ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1 J. Biol. Chem. 279 2004 10042 10051
35. G. Hashimoto, M. Shimoda, and Y. Okada ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan J. Biol. Chem. 279 2004 32483 32491
36. G.J. Wayne, S.J. Deng, A. Amour, S. Borman, R. Matico, H.L. Carter, and G. Murphy TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4 J. Biol. Chem. 282 2007 20991 20998
37. G. Gao, J. Westling, V.P. Thompson, T.D. Howell, P.E. Gottschall, and J.D. Sandy Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation J. Biol. Chem. 277 2002 11034 11041
38. L. Troeberg, K. Fushimi, S.D. Scilabra, H. Nakamura, V. Dive, I.B. Thøgersen, J.J. Enghild, and H. Nagase The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3 Matrix Biol. 28 2009 463 469
39. L.S. Lohmander, P.J. Neame, and J.D. Sandy The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis Arthritis Rheum. 36 1993 1214 1222
40. J.D. Sandy, C.R. Flannery, P.J. Neame, and L.S. Lohmander The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain J. Clin. Invest. 89 1992 1512 1516
41. J.D. Sandy, and C. Verscharen Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo Biochem. J. 358 2001 615 626
42. T. Samiric, M.Z. Ilic, and C.J. Handley Large aggregating and small leucine-rich proteoglycans are degraded by different pathways and at different rates in tendon Eur. J. Biochem./FEBS J. 271 2004 3612 3620
43. M.A. Pratta, W. Yao, C. Decicco, M.D. Tortorella, R.Q. Liu, R.A. Copeland, R. Magolda, R.C. Newton, J.M. Trzaskos, and E.C. Arner Aggrecan protects cartilage collagen from proteolytic cleavage J. Biol. Chem. 278 2003 45539 45545
44. M.D. Tortorella, R.Q. Liu, T. Burn, R.C. Newton, and E. Arner Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4) Matrix Biol. 21 2002 499 511
45. S. Porter, S.D. Scott, E.M. Sassoon, M.R. Williams, J.L. Jones, A.C. Girling, R.Y. Ball, and D.R. Edwards Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma Clin. Cancer Res. 10 2004 2429 2440
46. J. Held-Feindt, E.B. Paredes, U. Blömer, C. Seidenbecher, A.M. Stark, H.M. Mehdorn, and R. Mentlein Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas Int. J. Cancer 118 2006 55 61
47. H. Stanton, J. Melrose, C.B. Little, and A.J. Fosang Proteoglycan degradation by the ADAMTS family of proteinases Biochim. Biophys. Acta 1812 2011 1616 1629
48. J.D. Sandy, J. Westling, R.D. Kenagy, M.L. Iruela-Arispe, C. Verscharen, J.C. Rodriguez-Mazaneque, D.R. Zimmermann, J.M. Lemire, J.W. Fischer, T.N. Wight, and A.W. Clowes Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4 J. Biol. Chem. 276 16 2001 13372 13378